Stocktoria
Covista Inc. CVSA
Covista Inc. (CVSA) earns a Piotroski F-score of 7/9 (strong financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 0.26% (safety: no dividend). FY2025 revenue was $2.0B at a 12.9% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -2.74 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Recent analyst actions
| Date | Firm | Rating |
|---|---|---|
| 2026-06-08 | Barrington Research | Outperform (main) |
| 2026-05-11 | Truist Securities | Buy (main) |
| 2026-04-17 | Barrington Research | Outperform (main) |
| 2026-03-24 | Truist Securities | Buy (init) |
| 2026-03-02 | Barrington Research | Outperform (main) |
| 2026-01-29 | Barrington Research | Outperform (main) |
Wall Street analyst consensus — a sentiment gauge, not our scoring.
Smart money · insiders, last 12 months
Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.
How it ranks in Services · percentile among 982 companies
Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 7/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | -0.033 |
| Retained earnings / assets | 1.009 |
| EBIT / assets | 0.124 |
| Equity / liabilities | 1.087 |
Sector peers · similar-size Services companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| CVSA | Covista Inc. | 7/9 | 5.05 | 17.3 | +9.3% |
| STG | Sunlands Technology Group | 8/9 | 0.28 | — | +1.5% |
| LAUR | LAUREATE EDUCATION, INC. | 5/9 | 2.7 | 18.4 | +8.6% |
| LRN | Stride, Inc. | 7/9 | 7.97 | 11 | +4.7% |
| STRA | Strategic Education, Inc. | 6/9 | 5.58 | 14.1 | +4% |
| LOPE | Grand Canyon Education, Inc. | 5/9 | 15.74 | 17.8 | +7.1% |
| TAL | TAL Education Group | 7/9 | 4.37 | 9.3 | +33.7% |
About Covista Inc.
Covista Inc., together with its subsidiaries, provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. It operates in three segments: Chamberlain, Walden, and Medical and Veterinary. The company offers degree and non-degree programs, including bachelor's, master's, and doctoral degrees; and online certificate programs for nursing, health professions, medical, and veterinary postsecondary education, counseling, business, information technology, psychology, public health, social work and human services, public administration and public policy, and criminal justice. It also operates Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. The company was formerly known as Adtalem Global Education Inc. and changed its name to Covista Inc. in February 2026. Covista Inc. has a strategic collaboration agreement with Advocate Health to expand access to nursing education and build a direct pipeline of practice-ready nurses across the communities Advocate Health serves. Covista Inc. was incorporated in 1987 and is headquartered in Chicago, Illinois.
FAQ
Is CVSA financially healthy?
Covista Inc.'s Piotroski F-score is 7/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does CVSA pay a dividend, and is it safe?
Yes. Covista Inc. pays a dividend yielding about 0.26% with a None payout ratio, rated “no dividend” for safety.
How profitable is CVSA?
In FY2025, Covista Inc. had a net margin of 12.9% and a return on equity of 17.4%.
Is CVSA overvalued or undervalued?
Covista Inc. trades at about 18.2× trailing earnings — below its 10-year norm (10-year range 6.2×–101.0×, median 21.1×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for CVSA?
The average Wall-Street price target for Covista Inc. is $156.25, about 21.9% above the recent price, from 4 analysts (consensus: strong buy).
Is CVSA a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Covista Inc.: a Piotroski F-score of 7/9, an Altman Z″ in the safe zone, a P/E of about 17.3×, a dividend yield of 0.26%. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-06-30. Facts plus Stocktoria's own computed scores — not investment advice.